51 – 60 of 65
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2003
-
Mark
Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.
Becker, Charlotte LU ; Piironen, Timo ; Pettersson, Kim ; Hugosson, Jonas and Lilja, Hans LU
(2003)
In Journal of Urology
170(4 Pt 1).
p.1169-1174
- Contribution to journal › Article
-
Mark
Prostate specific antigen and human glandular kallikrein 2 in early detection of prostate cancer
- Contribution to journal › Scientific review
- 2002
-
Mark
Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen
Steuber, T ; Nurmikko, P ; Haese, A ; Pettersson, K ; Graefen, M ; Hammerer, P ; Huland, H and Lilja, Hans LU
(2002)
In Journal of Urology
168(5).
p.1917-1922
- Contribution to journal › Article
-
Mark
MRI-guided thermal therapy of transplanted tumors in the canine prostate using a directional transurethral ultrasound applicator
Hazle, John D ; Diederich, Chris J ; Kangasniemi, Marko ; Price, Roger E ; Olsson, Lars E LU
and Stafford, R Jason
(2002)
In Journal of Magnetic Resonance Imaging
15(4).
p.17-409
- Contribution to journal › Article
- 2000
-
Mark
Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer
Bratt, O LU ; Damber, J E ; Emanuelsson, M ; Kristoffersson, U LU ; Lundgren, R ; Olsson, Håkan LU
and Grönberg, H
(2000)
In European Journal of Cancer
36(2).
p.235-241
- Contribution to journal › Article
- 1999
-
Mark
Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy
Lilja, Hans LU
; Haese, A
; Björk, Thomas
LU
; Friedrich, M G
; Piironen, T
; Pettersson, K
; Huland, E
and Huland, H
(1999)
In Journal of Urology
162(6).
p.2029-2035
- Contribution to journal › Article
-
Mark
CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
Bratt, O LU ; Borg, Åke LU ; Kristoffersson, U LU ; Lundgren, R ; Zhang, Q X LU and Olsson, Håkan LU
(1999)
In British Journal of Cancer
81(4).
p.6-672
- Contribution to journal › Article
-
Mark
Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study
Bratt, O LU ; Kristoffersson, U LU ; Lundgren, R and Olsson, Håkan LU
(1999)
In European Journal of Cancer
35(2).
p.7-272
- Contribution to journal › Article
-
Mark
Cancer risks in BRCA2 mutation carriers
- Contribution to journal › Article
- 1998
-
Mark
Clinical course of early onset prostate cancer with special reference to family history as a prognostic factor
Bratt, O LU ; Kristoffersson, U LU ; Olsson, Håkan LU
and Lundgren, R
(1998)
In European Urology
34(1).
p.19-24
- Contribution to journal › Article